查看文章

The new coronavirus disease (COVID-19) has drawn the interest of mental health and neuroscience research, with emerging literature illustrating potential psychiatric and neurological manifestations following the COVID-19 infection (Varatharaj et al., 2020; Rogers et al., 2020; Pierce et al., 2020; Taquet et al., 2020). Recently, it was published a large retrospective cohort study conducted in US with a sample of 62 354 patients suggesting a bidirectional association between COVID-19 and psychiatric disorders, particularly anxiety and mood disorders (Taquet et al., 2020). In this study, the diagnosis of COVID-19 was independently associated with greater risk for psychiatric disorders, in the following 14–90 days, when compared with other acute conditions (eg influenza, respiratory infection, skin infection, fracture). Additionally, a psychiatric diagnosis confirmed in the previous year (prior to the infection) was …